News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Seeks More Data On Amylin Pharmaceuticals, Inc. (AMLN), Eli Lilly and Company (LLY) and Alkermes (ALKS) Diabetes Drug


10/20/2010 7:19:09 AM

LOS ANGELES, Oct 19 (Reuters) - U.S. health regulators declined on Tuesday to approve a diabetes drug being developed by Amylin Pharmaceuticals Inc's (AMLN.O) and Eli Lilly and Co (LLY.N), citing the need for further studies, including the drug's effect on heart rate.

Read at Reuters
Read at ABC News
Read at MedPageToday
Read at The Street.com

comments powered by Disqus
 
 
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES